354 related articles for article (PubMed ID: 26036354)
1. A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.
Stolbach A; Paziana K; Heverling H; Pham P
J Med Toxicol; 2015 Sep; 11(3):326-41. PubMed ID: 26036354
[TBL] [Abstract][Full Text] [Related]
2. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interactions of drugs with St John's wort.
Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
[TBL] [Abstract][Full Text] [Related]
4. Interactions between recreational drugs and antiretroviral agents.
Antoniou T; Tseng AL
Ann Pharmacother; 2002 Oct; 36(10):1598-613. PubMed ID: 12243611
[TBL] [Abstract][Full Text] [Related]
5. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.
Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
Drugs Aging; 2005; 22(6):525-39. PubMed ID: 15974642
[TBL] [Abstract][Full Text] [Related]
6. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
7. Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines.
Müller AC; Kanfer I
Biopharm Drug Dispos; 2011 Nov; 32(8):458-70. PubMed ID: 22024968
[TBL] [Abstract][Full Text] [Related]
8. Herb-drug interactions: a literature review.
Hu Z; Yang X; Ho PC; Chan SY; Heng PW; Chan E; Duan W; Koh HL; Zhou S
Drugs; 2005; 65(9):1239-82. PubMed ID: 15916450
[TBL] [Abstract][Full Text] [Related]
9. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
[TBL] [Abstract][Full Text] [Related]
10. Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.
Clevenbergh P; Mouly S; Sellier P; Badsi E; Cervoni J; Vincent V; Trout H; Bergmann JF
Curr HIV Res; 2004 Oct; 2(4):309-21. PubMed ID: 15544452
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.
Bazzoli C; Jullien V; Le Tiec C; Rey E; Mentré F; Taburet AM
Clin Pharmacokinet; 2010; 49(1):17-45. PubMed ID: 20000887
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products.
Brooks KM; George JM; Kumar P
Expert Rev Clin Pharmacol; 2017 Jan; 10(1):59-79. PubMed ID: 27715369
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.
Chauvin B; Drouot S; Barrail-Tran A; Taburet AM
Clin Pharmacokinet; 2013 Oct; 52(10):815-31. PubMed ID: 23703578
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.
Ma Q; Okusanya OO; Smith PF; Dicenzo R; Slish JC; Catanzaro LM; Forrest A; Morse GD
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):473-85. PubMed ID: 16863456
[TBL] [Abstract][Full Text] [Related]
16. Interactions between antiretrovirals and antineoplastic drug therapy.
Antoniou T; Tseng AL
Clin Pharmacokinet; 2005; 44(2):111-45. PubMed ID: 15656694
[TBL] [Abstract][Full Text] [Related]
17. The role of cytochrome P450 in antiretroviral drug interactions.
Walubo A
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):583-98. PubMed ID: 17696808
[TBL] [Abstract][Full Text] [Related]
18. Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review.
Bordes C; Leguelinel-Blache G; Lavigne JP; Mauboussin JM; Laureillard D; Faure H; Rouanet I; Sotto A; Loubet P
Clin Microbiol Infect; 2020 Sep; 26(9):1161-1170. PubMed ID: 32360208
[TBL] [Abstract][Full Text] [Related]
19. Delavirdine: a review of its use in HIV infection.
Scott LJ; Perry CM
Drugs; 2000 Dec; 60(6):1411-44. PubMed ID: 11152019
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment.
Gong Y; Haque S; Chowdhury P; Cory TJ; Kodidela S; Yallapu MM; Norwood JM; Kumar S
Expert Opin Drug Metab Toxicol; 2019 May; 15(5):417-427. PubMed ID: 30951643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
